Programmaschema Chicago op Schier 2023

zie hyperlinks hieronder voor de vervolgdagen

Zondag 4 juni 2023

11.30 uur  Verzamelen Restaurant Waddengenot aan Zee, Zeedijk 1, Lauwersoog
12.30 uur Overtocht met de boot naar Schiermonnikoog
13.15 uur De pendelbus brengt u naar Hotel Van der Werff
13.30 uur Wandeling van Van der Werff naar het Dorpshuis, Torenstreek 18-A

14.00 uur Opening en start programma: Virtual ASCO – Locatie: Dorpshuis

Educational The early stage triple negative breast cancer journey: Beginning, end and everything in between. (30 min.)

1. Stringer Neoadjuvant Therapy in Triple-Negative Breast Cancer: Where We Are and What’s Next? 
2. Han Tailoring Post-Neoadjuvant Therapy in TNBC. 

Educational State of the art in pancreatic cancer (30 min)

1. Syed Ahmad State of the Art & New Developments in Surgery for Pancreatic Cancer 
2. Mark O’ Hara State of the Art & New Developments in Systemic Therapy for Pancreatic Cancer

15.00-15.15 pauze

15.15-16.15 Oral abstracts (60 min)

1. Terashima ATTRACTION-5: A phase 3 study of nivolumab plus chemotherapy as postoperative adjuvant treatment for pathological stage III (pStage III) gastric or gastroesophageal junction (G/GEJ) cancer 14.45-14.57 Abs# 4000
2. Yuan Perioperative PD-1 antibody toripalimab plus SOX or XELOX chemotherapy versus SOX or XELOX alone for locally advanced gastric or gastro-oesophageal junction cancer: Results from a prospective, randomized, open-label, phase II trial 14.57-15.09 Abs# 4001
3. Ilson Is Timing Everything? Immunotherapy in Localized Gastroesophageal Junction and Gastric Cancer 15.09-15.21 Abstract discussion
4. Labori Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1) 16.33-16.45 Abs# LBA4005
5. O’Reilly Liposomal irinotecan + 5-fluorouracil/leucovorin + oxaliplatin (NALIRIFOX) versus nab-paclitaxel + gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC): 12- and 18-month survival rates from the phase 3 NAPOLI 3 trial 16.45-16.57 Abs# 4006

16.30 uur Live verbinding met Chicago: Hanneke van Laarhoven (upper GI)

17.00 uur Pauze + teruglopen naar Van der Werff

17.30 uur (besloten sessie) Klinische implicaties upper-GI bij vd Werff (Hanneke Wilmink)

18.30 uur Einde

19.30 uur Diner in restaurant Van der Werff

Maandag 5 juni 2023

Dinsdag 6 juni 2023

Woensdag 7 juni 2023